相关实验视频

Updated: Feb 22, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

纳米体工程 CLL-1 CAR-T 细胞:优化瘤特异性细胞毒性,最大限度地减少瘤以外的毒性

Chakrapani Tripathi¹, Sergey Zolov², John Nguyen¹

¹Sino-American Cancer Foundation Covina, California United States.

Cancer research communications

|February 21, 2026

概括

针对CLL-1的新纳米体CAR-T细胞在急性髓性白血病 (AML) 模型中显示出强大的抗白血病活性. 这种方法减少了瘤外的毒性,节省了健康的干细胞,以改善患者的治疗结果.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
在瘤学瘤学.

背景情况:

急性髓性白血病 (AML) 是一种具有不良预后的侵袭性癌症.
化学抗原受体 (CAR) T细胞疗法显示出希望,但由于毒性,AML面临挑战.
针对髓受限抗原对于有效的AML免疫疗法至关重要.

研究的目的:

开发和评估一个基于纳米体的CAR-T细胞平台,针对用于AML治疗的CLL-1抗原.
将CLL-1 CAR-T细胞与CD33 CAR-T细胞的疗效和安全性进行比较.
评估纳米体CAR-T细胞克服AML免疫治疗当前局限性的潜力.

主要方法:

工程纳米体CAR构建了针对CLL-1和CD33.3的目标.
在IncuCyte实时细胞毒性测试.
序列瘤重新挑战测试.
在体内评估疗效的NSG异种移植模型.

主要成果:

无论是CLL-1还是CD33的CAR-T细胞都表现出强大的抗白血病活性.
CLL-1 CAR-T细胞选择性地向AML爆发,同时省略了正常的造血祖先.
CLL-1 CAR-T细胞保持了有利的记忆表型,增殖和活力.
细胞因子释放试验证实了抗原特异性免疫激活.

结论:

针对CLL-1的纳米体CAR-T细胞代表了针对AML的有前途的精确免疫疗法.
这种方法提供了强大的抗白血病活性,降低了目标外毒性.
纳米体CAR-T细胞增强了转化潜力,可以改善AML患者的治疗结果.

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.